The data summarized here have led to a new hypothesis that can better explain the mechanisms by which VPF/VEGF acts in vivo to induce stroma formation; it also offers a possible explanation for the limited effectiveness of anti-VEGF cancer therapies. This evidence concerns the gene VEGFA and cancer.